Shannon’s husband, Kyle, immediately volunteered to begin testing as a potential living donor — not just for her, but for ...

Family of Hope Cartwright, Virginia Living Magazine editor killed in Richmond hit-and-run, releases statement asking for privacy while grieving. Man shot, killed by Secret Service outside of ...

RICHMOND, Va. — Hope Cartwright, a 23-year-old associate editor at Virginia Living magazine, was hit and killed as she walked across Cary and 2nd streets in downtown Richmond on Monday evening, ...

Winter storm maps show states to get hit hardest later this week USA vs. Canada: The Rock 'Em, Sock 'Em Olympic hockey final you cannot skip Something is happening with orcas at sea - The attacks are ...

A new story by Melinda Salchert lets readers know right up front that her pick is in a “charming coastal town,” which turns out to be Fairhope. The venue is The Hope Farm, which Salchert describes as ...

The treatment has been approved for NHS use, offering new hope to the nearly 12,000 people in England living with lupus nephritis. Obinutuzumab (Gazyvaro), a twice-yearly infusion that, combined with ...

The first leukaemia patient receives a breakthrough treatment since it was made available on the NHS and commented that it was "fantastic" and "very sci-fi." Oscar Murphy, who has an aggressive form ...

One of the quieter lessons the holiday season teaches is how to manage disappointment. We learn the gap between expectation and reality — the holiday photos that don’t quite turn out, the family ...

A new field survey by the Samoa Conservation Society has confirmed several sightings of the critically endangered manumea, or little dodo, in remote rainforest areas. The rare observations, the first ...

A bankruptcy judge blocked an attempt by a nursing home chain’s primary investor to shield himself from settlement payments and liability in lawsuits alleging hundreds of patient injuries and deaths — ...

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (“Belite Bio” or the “Company”) today announced topline results from the global Phase 3 “DRAGON” trial of Tinlarebant, marking the first ...